Effect of picrotoxin on antinociception in the formalin test.

Subcutaneous injection of diluted formalin (0.25 microliter of 0.5%) caused a biphasic pain response in mice. The first phase of pain was observed during the first 5 min., while the second phase occurred 10-30 min. after formalin administration. With the formalin test, it was found that the antinociception produced by the GABA-A antagonist, picrotoxin, and the GABA-B antagonist, phaclofen, was abolished when employed in combination. The opioid antagonist naloxone and antimuscarinic atropine also decreased the picrotoxin response. However, sulpiride, SCH 23390, phenoxybenzamine and propranolol did not alter the picrotoxin response. Administration of naloxone, sulpiride and propranolol showed a pain response. The data indicate that dopaminergic and adrenergic mechanisms may not be involved in the picrotoxin antinociceptive effect. However, postsynaptic GABA-A and GABA-B may be involved in the drug effect, and involvement of opioid or cholinergic systems can not be excluded.

[1]  R. Inoki,et al.  Modified formalin test: characteristic biphasic pain response , 1989, Pain.

[2]  M. Raiteri,et al.  Release‐regulating autoreceptors of the GABAB‐type in human cerebral cortex , 1989, British journal of pharmacology.

[3]  L. Kocher.  Systemic naloxone does not affect pain-related behaviour in the formalin test in rat , 1988, Physiology & Behavior.

[4]  I. Soltesz,et al.  The GABAB antagonist phaclofen inhibits the late K+-dependent IPSP in cat and rat thalamic and hippocampal neurones , 1988, Brain Research.

[5]  D. R. Curtis,et al.  Phaclofen: a peripheral and central baclofen antagonist , 1987, Brain Research.

[6]  J. Sawynok.  GABAergic mechanisms of analgesia: An update , 1987, Pharmacology Biochemistry and Behavior.

[7]  J. C. Stoof,et al.  Two dopamine receptors: biochemistry, physiology and pharmacology. , 1984, Life sciences.

[8]  J. Hyttel.  Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390 , 1984, Neuropharmacology.

[9]  K. Dunlap.  Functional and pharmacological differences between two types of GABA receptor on embryonic chick sensory neurons , 1984, Neuroscience Letters.

[10]  P. Feltz,et al.  Coexistence of GABAA and GABAB receptors on Aδ and C primary afferents , 1984 .

[11]  G. Maksay,et al.  Convulsant/depressant site of action at the allosteric benzodiazepine-GABA receptor-ionophore complex. , 1983, Life sciences.

[12]  I. Martin,et al.  Is GABA release modulated by presynaptic receptors? , 1978, Nature.

[13]  D. Dubuisson,et al.  The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats , 1977, Pain.

[14]  G. Chiara,et al.  Evidence for dopamine receptors mediating sedation in the mouse brain , 1976, Nature.

[15]  M. Zarrindast,et al.  Influences of dopamine agonists and antagonists of baclofen antinociception in mice. , 1991, Archives internationales de pharmacodynamie et de therapie.

[16]  M. Zarrindast,et al.  GABAA-antagonists and baclofen analgesia. , 1988, General pharmacology.

[17]  M. Valli,et al.  Antinociceptive action of picrotoxin in the mouse. , 1986, General pharmacology.

[18]  N. Bowery.  Baclofen: 10 years on , 1982 .